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The Effectiveness of Oral Non-Steroidal Anti-Inflammatories Versus Steroid 
Injections in Patients with Shoulder Pain 
Darren Pledger PT, DPT, PA-S
• The fact that shoulder pain is the third most common 
musculoskeletal complaint in primary care shows that clinicians 
must have an arsenal of quality interventions to treat this 
problem.  
• The need for quality research and evidenced based guidelines 
are necessary to educate clinicians on their treatment options, 
the efficacy of those treatments, and their safety profiles. 
Theme 1
• Adebajo, Nash, and Hazleman, (1990), found both oral NSAIDs 
(p=0.0268) and triamcinolone injection are superior to placebo 
with the steroid injection group achieving the greatest results.  
• Berry, Fernandes, Bloom, Clark, and Hamilton (1980) found 
that all groups showed statistically significant improvement in 
pain and range of motion but no significant difference between 
groups with no distinct advantage of any treatment. 
• Petri, Dobrow, Neiman, Whiting-O'keefe, and Seaman (1987) 
found that steroid injection (p=0.00005) and oral NSAIDs 
(p=0.02) were statistically superior to placebo and that there 
was no statistical significance of combined treatment compared 
to steroid injection alone. 
1. In patients with shoulder pain, is oral non-steroidal anti-
inflammatories or corticosteroid injections into the glenohumeral 
joint more effective in reducing shoulder pain?
2. What are the risks and side effects of oral non-steroidal anti-
inflammatories and corticosteroid injections into the glenohumeral 
joint when used to treat shoulder pain?
• Adebajo, A. O., Nash, P., & Hazleman, B. L. (1990). A prospective double-blind 
dummy placebo controlled study comparing triamcinolone hexacetonide injection with 
oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. The Journal of 
Rheumatology, 17(9), 1207-1210. Available from http://www.jrheum.org/
• Berry, H., Fernandes, L., Bloom, B., Clark, R. J., & Hamilton, E. B. D. (1980). Clinical 
study comparing acupuncture, physiotherapy, injection and oral anti-inflammatory 
therapy in shoulder-cuff lesions. Current Medical Research and Opinion, 7(2), 121-126. 
http://doi.org/10.1185/03007998009112038
• Petri, M., Dobrow, R., Neiman, R., Whiting-O'keefe, Q., & Seaman, W. E. (1987). 
Randomized, double-blind, placebo-controlled study of the treatment of the painful 
shoulder. Arthritis & Rheumatology, 30, 1040–1045. 
http://doi.org/10.1002/art.1780300911
• Ranalletta, M., Rossi, L. A., Bongiovanni, S. L., Tanoira, I., Elizondo, C. M., & 
Maignon, G. D. (2016). Corticosteroid injections accelerate pain relief and recovery of 
function compared with oral NSAIDs in patients with adhesive capsulitis. The American 
Journal of Sports Medicine, 44(2), 474-481. http://doi.org/10.1177/0363546515616238
• Shin, S., & Lee, S. (2013). Efficacies of corticosteroid injection at different sites of the 
shoulder for the treatment of adhesive capsulitis. Journal of Shoulder and Elbow 
Surgery, 22(4), 521-527. http://doi.org/10.1016/j.jse.2012.06.015
• Sun, Y., Chen, J., Li, H., Jiang, J., & Chen, S. (2015). Steroid injection and nonsteroidal 
anti-inflammatory agents for shoulder pain: A PRISMA systematic review and meta-
analysis of randomized controlled trials. Medicine, 94(50), 1-8. http://doi.org/ 
10.1097/MD.0000000000002216
• Nissen, S., Yeomans, N., Solomon, D., Luscher, T., Libby, P., Husni, M., & Lincoff, M. 
for the PRECISION Trial Investigators. (2016). Cardiovascular safety of celecoxib, 
naproxen, or ibuprofen for arthritis. The New England Journal of Medicine, 
375(26),2519-2529. http://doi.org/10.1056/NEJMoa1611593
• Castellsague, J., Riera-Guardia, N., Calingaert, B., Varas-Lorenzo, C., Fourrier-Reglat, 
A., Nicotra, F., . . . & Perez-Gutthann, S. (2012). Individual NSAIDs and upper 
gastrointestinal complication: A systematic review and meta-analysis of observational 
studies (the SOS Project). Drug Safety, 35(12), 1127-1146. 
https://doi.org/10.1007/BF03261999
• Zhang, X., Donnan, P. T., Bell, S., & Guthrie, B. (2017). Non-steroidal anti-
inflammatory drug induced acute kidney injury in the community dwelling general 
population and people with chronic kidney disease: Systematic review and meta-
analysis. BMC Nephrology, 18, 256. http://doi.org /10.1186/s12882-017-0673-8
• Patrono, C. (2016) Cardiovascular effects of nonsteroidal anti-inflammatories. Current 
Cardiology Reports, 18(25), 1-8. https://doi-org /10.1007/s11886-016-0702-4
• Rostom, A., Muir, K., Dube, C., Jolicoeur, E., Boucher, M., Joyce, J., & Wells, G. 
(2011). Gastrointestinal safety of cyclooxygenase-2 inhibitors: A Cochrane 
collaboration systematic review. Clinical Gastroenterology and Hepatology, 5(7), 818-
828. http://doi.org/10.1016/j.cgh.2007.03.011 
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• Ranalletta et al. found that pain was improved at all time points 
regardless of treatment group.  However, relief was achieved 
faster in the corticosteroid injection group.  This was 
statistically significant up to eight weeks (p=<.001), but lost 
significance (p=.825) at 12 weeks as pain improved in the oral 
NSAID group.
• Shin and Lee (2013) found that all patients treated with 
corticosteroids, regardless of group, demonstrated statistically 
significant (p=<.05) faster pain relief and functional recovery 
up to 16 weeks compared to oral NSAIDs.  Although 
corticosteroids were found to achieve faster results, at 24 weeks 
there was no statistical difference (p=.670) in outcomes for all 
four groups.
• Sun, Chen, Li, Jiang, and Chen (2015)  found that in terms of 
functional improvement, steroid injections showed superiority 
to oral NSAIDs (standard mean difference (SMD) 0.61; 95%CI, 
0.08–1.14, p=0.01) and found no superiority in either treatment 
in pooled results in regard to pain relief (SMD 0.45; 
95%CI,0.50–1.40, p<0.00001). 
Discussion
• Many of the studies comparing corticosteroids to oral NSAIDs 
yielded similar results (Berry et al., 1980; Deghan et al., 2013; 
Petri et al., 1987; Ranelleta et al., 2016; Sun et al., 2015). 
• Two studies found that corticosteroids and oral NSAIDs are 
both superior to placebo in treating shoulder pain (Adebajo et 
al., 1990; Petri et al., 1987).
• Three studies found with statistical significance, that 
corticosteroids accelerate pain relief when compared to oral 
NSAIDs but long-term pain relief was equivocal (Dehghan et 
al., 2013; Ranelleta et al., 2016; Shin & Lee, 2013).
• Many of the studies in theme one had very small sample sizes.
• There is a small amount of literature directly comparing oral 
NSAIDs to corticosteroid injection. 
• A wide range of shoulder conditions were studied in theme one 
lacking consistency.  
• Many studies in theme one were dated.  
• Zhang, Donnan, Bell, and Guthrie (2017) found that taking 
NSAIDs was associated in a 1.5-fold increase in the odds of 
developing AKI in the general population in people with (OR 
1.63, 95%CI: 1.22–2.19, p=0.009) and without CKD (OR 1.73 
95%CI: 1.44–2.07, p < 0.001). 
• Patrono (2016) determined that traditional NSAIDS and coxibs
increased the risk of major vascular events by 40% with the 
exception of naproxen. 
• Rostom et al. (2011) found a clear advantage of selective COX-
2s over nonselective NSAIDs on gastrointestinal safety with 
fewer gastroduodenal ulcers (RR 0.26, 95%CI: 0.23-0.30) and 
fewer complications from ulcers (RR 0.39, 95%CI: 0.31-0.50).
Theme 2
• Nissen et al. (2016), Precision Trial, found statistically 
significant results that there is no greater cardiovascular risk 
from celecoxib when compared to naproxen or ibuprofen.
• Castellsague et al. (2012), for individual NSAID use, they 
determined that ibuprofen was in the lowest range of pooled 
RRs while naproxen was associated with higher RR values 
depending on certain doses.
• There is a risk for upper gastrointestinal complications 
(Castellsague et al., 2012; Chang et al., 2011; Garcia 
Rodriquez & Barreales Tolosa, 2007; Rostom et al., 2011; 
Nissen et al., 2016).
• Non-selective oral NSAIDs pose the greatest risk followed by 
selective oral NSAIDs.  Although selective oral NSAIDs were 
found to decrease the risk of upper gastrointestinal 
complications, they found that taking aspirin with selective 
NSAIDs virtually cancels out their gastroprotective effect 
(Garcia Rodriquez & Barreales Tolosa, 2007)
• The studies showed an increase in cardiovascular risk to a 
varying degree of all NSAIDs (Chang et al., 2011; Nissen et 
al., 2016; Patrono, 2016).
• All NSAIDs pose a risk to the kidney and AKI is possible in 
healthy populations as well as the elderly (Chou et al., 2016; 
Zhang et al., 2017).
• Both oral NSAIDs and corticosteroid injection are effective in 
reducing shoulder pain.
• Both treatments can treat a wide range of conditions.
• Both are superior to placebo while neither is superior to the 
other, thus the decision on what treatment to use should be 
based on an individuals comorbidities and risk factors.  
• There are side effects associated with both treatments.
Literature Review
